What type of study is this?

This is a In Vitro Study study.

What question did this study set out to answer?

This research aimed to investigate the role of resolvins in modulating haematopoietic stem cells and neutrophil activation in sickle cell disease.

December 8, 2025BloodOpen Access

Resolvins modulate haematopoietic stem and progenitor cell dysfunction and neutrophil activation in sickle cell disease

View Full Paper

Ask AI

Bookmark

Authors

VGVishaka GorurQueen Mary University of London DKDuco S. KoenisWilliam Harvey Research Institute MBMonika BuczekTaconic (United States)

Discussion

Member takes

Implication

Experimental findings suggest resolvins mitigate neutrophil dysfunction and restore HSC function in sickle cell disease, indicating potential therapeutic avenues.

Key Points

This research aimed to investigate the role of resolvins in modulating haematopoietic stem cells and neutrophil activation in sickle cell disease.
Differentiated CD34+ cells from SCD patients and healthy donors into neutrophils using StemSpan™ Myeloid Expansion Supplement.
Measured neutrophil yield, oxidative stress, and CD11b expression among neutrophils from SCD and healthy donors.
Conducted in vivo experiments by transplanting SCD or control HSCs into HuNOG-EXL mice and assessing neutrophil characteristics post-transplantation.
Evaluated the effects of resolvins on neutrophil function in vitro and in vivo to confirm restoration of HSC function.
SCD-derived CD34+ cells yielded significantly more neutrophils than those from healthy donors.
Neutrophils from SCD showed higher oxidative stress and CD11b expression compared to controls.
In resolvin-treated mice, there was a greater than 40% reduction in neutrophil proportions and CD11b expression compared to vehicle-treated controls.
Mice receiving resolvin-treated SCD HSCs exhibited a higher proportion of human CD34+ cells in bone marrow, indicating improved HSC function.

Cite This Study

Gorur et al. (2025) studied this question.

synapsesocial.com/papers/69362f7d4fa91c937236e481 https://doi.org/10.1182/blood-2025-1148

View Full Paper

Ask AI

Bookmark

Implication

Experimental findings suggest resolvins mitigate neutrophil dysfunction and restore HSC function in sickle cell disease, indicating potential therapeutic avenues.

Resolvins modulate haematopoietic stem and progenitor cell dysfunction and neutrophil activation in sickle cell disease

Discussion

Member takes

Implication

Key Points

Cite This Study

Resolvins modulate haematopoietic stem and progenitor cell dysfunction and neutrophil activation in sickle cell disease

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider